Episode 12: Skin Toxicities from Immune Checkpoint Inhibitors (PART 1): Common and perplexing

https://is1-ssl.mzstatic.com/image/thumb/Podcasts114/v4/8a/61/9e/8a619eda-4370-c5a1-6a8d-8ed30aac4c4f/mza_12824525197888336905.jpg/600x600bb.jpg

Checkpoint NOW

Afreen Shariff

32 episodes

1 week ago

All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.

Medicine

Health & Fitness

RSS

All content for Checkpoint NOW is the property of Afreen Shariff and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded/7711112/7711112-1605830906092-4f856047119d3.jpg

Episode 12: Skin Toxicities from Immune Checkpoint Inhibitors (PART 1): Common and perplexing

Checkpoint NOW

17 minutes 59 seconds

4 years ago

Episode 12: Skin Toxicities from Immune Checkpoint Inhibitors (PART 1): Common and perplexing

Learn from the experts about the latest in Onco- Dermatology and Immune skin Mediated toxicities. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest expert and Dermatologist Dr. Meenal Kheterpal. Dr. Kheterpal is a Dermatologist, Assistant Professor of Dermatology at Duke University School of Medicine. She also directs clinical research in Melanoma and Non - Melanoma Skin Cancer at Duke Dermatology.